D.A. Davidson & Co’s aTyr Pharma ATYR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $160K | Sell |
31,650
-8,550
| -21% | -$43.3K | ﹤0.01% | 1386 |
|
|
2025
Q1 | $121K | Buy |
40,200
+1,200
| +3% | +$3.62K | ﹤0.01% | 1361 |
|
|
2024
Q4 | $141K | Buy |
39,000
+10,000
| +34% | +$36.2K | ﹤0.01% | 1362 |
|
|
2024
Q3 | $51K | Buy |
29,000
+1,150
| +4% | +$2.02K | ﹤0.01% | 1357 |
|
|
2024
Q2 | $43.4K | Buy |
27,850
+1,500
| +6% | +$2.34K | ﹤0.01% | 1341 |
|
|
2024
Q1 | $51.4K | Buy |
26,350
+13,600
| +107% | +$26.5K | ﹤0.01% | 1359 |
|
|
2023
Q4 | $18K | Sell |
12,750
-10,000
| -44% | -$14.1K | ﹤0.01% | 1343 |
|
|
2023
Q3 | $35.9K | Hold |
22,750
| – | – | ﹤0.01% | 1302 |
|
|
2023
Q2 | $49.1K | Buy |
22,750
+10,750
| +90% | +$23.2K | ﹤0.01% | 1312 |
|
|
2023
Q1 | $25.2K | Sell |
12,000
-800
| -6% | -$1.68K | ﹤0.01% | 1321 |
|
|
2022
Q4 | $28K | Buy |
12,800
+1,000
| +8% | +$2.19K | ﹤0.01% | 1290 |
|
|
2022
Q3 | $35K | Buy |
11,800
+1,000
| +9% | +$2.97K | ﹤0.01% | 1255 |
|
|
2022
Q2 | $31K | Buy |
+10,800
| New | +$31K | ﹤0.01% | 1253 |
|
|
2017
Q2 | – | Sell |
-143
| Closed | -$7K | – | 2454 |
|
|
2017
Q1 | $7K | Hold |
143
| – | – | ﹤0.01% | 2118 |
|
|
2016
Q4 | $4K | Buy |
+143
| New | +$4K | ﹤0.01% | 2295 |
|
|
2016
Q3 | – | Sell |
-143
| Closed | -$5K | – | 2485 |
|
|
2016
Q2 | $5K | Buy |
+143
| New | +$5K | ﹤0.01% | 2133 |
|